<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9111820</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21573</journal-id>
<journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. Psychiatry</journal-id>
<journal-title-group>
<journal-title>European psychiatry : the journal of the Association of European Psychiatrists</journal-title>
</journal-title-group>
<issn pub-type="ppub">0924-9338</issn>
<issn pub-type="epub">1778-3585</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27318301</article-id>
<article-id pub-id-type="pmc">5483998</article-id>
<article-id pub-id-type="doi">10.1016/j.eurpsy.2016.03.004</article-id>
<article-id pub-id-type="manuscript">NIHMS869255</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genome-wide significant loci for addiction and anxiety</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hodgson</surname>
<given-names>K.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Almasy</surname>
<given-names>L.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Knowles</surname>
<given-names>E.E.M.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kent</surname>
<given-names>J.W.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Curran</surname>
<given-names>J.E.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dyer</surname>
<given-names>T.D.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Göring</surname>
<given-names>H.H.H.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olvera</surname>
<given-names>R.L.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fox</surname>
<given-names>P.T.</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pearlson</surname>
<given-names>G.D.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A7">g</xref>
<xref ref-type="aff" rid="A8">h</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krystal</surname>
<given-names>J.H.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A8">h</xref>
<xref ref-type="aff" rid="A9">i</xref>
<xref ref-type="aff" rid="A10">j</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duggirala</surname>
<given-names>R.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blangero</surname>
<given-names>J.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glahn</surname>
<given-names>D.C.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A7">g</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Department of psychiatry, Yale University, School of Medicine, New Haven, CT, USA</aff>
<aff id="A2"><label>b</label>South Texas Diabetes and Obesity Institute, University of Texas, Rio Grande Valley School of Medicine, Brownsville, TX, USA</aff>
<aff id="A3"><label>c</label>Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA</aff>
<aff id="A4"><label>d</label>Department of Psychiatry, University of Texas Health Science Center, San Antonio, TX, USA</aff>
<aff id="A5"><label>e</label>Research Imaging Institute, University of Texas Health Science Center, San Antonio, TX, USA</aff>
<aff id="A6"><label>f</label>South Texas Veterans Health System, 7400, Merton Minter, San Antonio, TX, USA</aff>
<aff id="A7"><label>g</label>Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA</aff>
<aff id="A8"><label>h</label>Department of Neurobiology, Yale University School of Medicine, New Haven, CT, USA</aff>
<aff id="A9"><label>i</label>Clinical Neuroscience Division, VA National Center for PTSD, VA Connecticut Healthcare System, West Haven, CT, USA</aff>
<aff id="A10"><label>j</label>Psychiatry Services, Yale-New Haven Hospital, New Haven, CT, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding author. Temple Medical Center, 40 Temple Street, 06510, New Haven, CT, USA. <email>karen.hodgson@yale.edu</email> (K. Hodgson)</corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>Disclosure of interest</bold>
</p>
<p>The authors declare that they have no competing interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>36</volume>
<fpage>47</fpage>
<lpage>54</lpage>
<!--elocation-id from pubmed: 10.1016/j.eurpsy.2016.03.004-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">Psychiatric comorbidity is common among individuals with addictive disorders, with patients frequently suffering from anxiety disorders. While the genetic architecture of comorbid addictive and anxiety disorders remains unclear, elucidating the genes involved could provide important insights into the underlying etiology.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">Here we examine a sample of 1284 Mexican-Americans from randomly selected extended pedigrees. Variance decomposition methods were used to examine the role of genetics in addiction phenotypes (lifetime history of alcohol dependence, drug dependence or chronic smoking) and various forms of clinically relevant anxiety. Genome-wide univariate and bivariate linkage scans were conducted to localize the chromosomal regions influencing these traits.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Addiction phenotypes and anxiety were shown to be heritable and univariate genome-wide linkage scans revealed significant quantitative trait loci for drug dependence (14q13.2–q21.2, LOD = 3.322) and a broad anxiety phenotype (12q24.32–q24.33, LOD = 2.918). Significant positive genetic correlations were observed between anxiety and each of the addiction subtypes (ρ<sub>g</sub> = 0.550–0.655) and further investigation with bivariate linkage analyses identified significant pleiotropic signals for alcohol dependence-anxiety (9q33.1–q33.2, LOD = 3.054) and drug dependence-anxiety (18p11.23–p11.22, LOD = 3.425).</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">This study confirms the shared genetic underpinnings of addiction and anxiety and identifies genomic loci involved in the etiology of these comorbid disorders. The linkage signal for anxiety on 12q24 spans the location of <italic>TMEM132D</italic>, an emerging gene of interest from previous GWAS of anxiety traits, whilst the bivariate linkage signal identified for anxiety-alcohol on 9q33 peak coincides with a region where rare CNVs have been associated with psychiatric disorders. Other signals identified implicate novel regions of the genome in addiction genetics.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Addiction</kwd>
<kwd>Anxiety</kwd>
<kwd>Comorbidity</kwd>
<kwd>Pleiotropy</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>